Sishan Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sishan Yan has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Dongmei Zhang
State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou, China
2 shared publications Jingwen Xie
2 shared publicationsJunqiu Zhang
2 shared publicationsMaohua Huang
2 shared publications- Minfeng Chen
State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China
2 shared publications Qun Miao
2 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (7) , 4426-4441
Targeting FAPα-positive hepatic stellate cells ameliorates the formation of pre-metastatic niche
- 1 May 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (7) , 4426-4441
Open AccessTargeting FAPα-positive hepatic stellate cells ameliorates the formation of pre-metastatic niche
- Open Access
- 2 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Pericytes promote metastasis by regulating tumor local vascular tone and hemodynamics
Hemodynamics are important for survival and extravasation of circulating tumor cells, whereas the effects of hemodynamics on tumor cell intravasation remain mostly unknown. Here, we show that colorectal cancer patients with liver metastasis are characterized by increased diameter and blood flow in the primary tumor compared with non-metastatic patients. A subpopulation of NKX2-3high tumor pericytes (TPCs) in the primary tumor is associated with hematogenous metastasis of patients. Mechanistically, long noncoding RNA NEAT1-enriched extracellular vesicles induce NKX2-3 upregulation in TPCs. NKX2-3 suppresses calcium influx in TPCs via PDE1C/cAMP/PKA signaling axis, inducing tumor vasodilation and increasing blood flux and vascular leakage. Genetic deletion of Nkx2-3 or pharmacological blocking the transcriptional activity of NKX2-3 in TPCs with designed peptide induce tumor local vasoconstriction and decrease blood flow to mitigate tumor metastasis. These findings reveal that TPCs-regulated vasodilation and hemodynamics facilitate tumor metastasis, and provide a potential prognostic marker and therapeutic strategy for tumor metastasis.
- 2 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Open AccessPericytes promote metastasis by regulating tumor local vascular tone and hemodynamics
Hemodynamics are important for survival and extravasation of circulating tumor cells, whereas the effects of hemodynamics on tumor cell intravasation remain mostly unknown. Here, we show that colorectal cancer patients with liver metastasis are characterized by increased diameter and blood flow in the primary tumor compared with non-metastatic patients. A subpopulation of NKX2-3high tumor pericytes (TPCs) in the primary tumor is associated with hematogenous metastasis of patients. Mechanistically, long noncoding RNA NEAT1-enriched extracellular vesicles induce NKX2-3 upregulation in TPCs. NKX2-3 suppresses calcium influx in TPCs via PDE1C/cAMP/PKA signaling axis, inducing tumor vasodilation and increasing blood flux and vascular leakage. Genetic deletion of Nkx2-3 or pharmacological blocking the transcriptional activity of NKX2-3 in TPCs with designed peptide induce tumor local vasoconstriction and decrease blood flow to mitigate tumor metastasis. These findings reveal that TPCs-regulated vasodilation and hemodynamics facilitate tumor metastasis, and provide a potential prognostic marker and therapeutic strategy for tumor metastasis.